Current openings at Zephyr AI

We envision a more informed approach to decision-making in drug development, one driven by data and tailored insights into patient selection.

Zephyr is pioneering an innovative AI platform aimed at revolutionizing cancer and cardiometabolic disease treatment paradigms. Through the aggregation of extensive real-world data (RWD) and the application of advanced machine learning techniques, we seek to deepen our understanding of biology, uncovering transformative insights that will reshape the development of new therapies and patient care practices.

For example our oncology models forecast how a patient's tumor will react to specific therapies, even with minimal clinical data and only next-generation sequencing (NGS) information about their tumor. 

ZephyrAI is dedicated to revolutionizing drug development processes, reforming clinical trial methodologies, and making precision medicine accessible to all.